Cite
Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study.
MLA
Zhang, Lei, et al. “Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study.” Cardiovascular and Interventional Radiology, vol. 44, no. 1, Jan. 2021, pp. 63–72. EBSCOhost, https://doi.org/10.1007/s00270-020-02579-2.
APA
Zhang, L., Sun, J.-H., Hou, Z.-H., Zhong, B.-Y., Yang, M.-J., Zhou, G.-H., Wang, W.-S., Huang, P., Zhang, S., Li, Z., Zhu, X.-L., Yan, Z.-P., & Ni, C.-F. (2021). Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study. Cardiovascular and Interventional Radiology, 44(1), 63–72. https://doi.org/10.1007/s00270-020-02579-2
Chicago
Zhang, Lei, Jun-Hui Sun, Zhong-Heng Hou, Bin-Yan Zhong, Min-Jie Yang, Guan-Hui Zhou, Wan-Sheng Wang, et al. 2021. “Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study.” Cardiovascular and Interventional Radiology 44 (1): 63–72. doi:10.1007/s00270-020-02579-2.